Skip to search formSkip to main contentSkip to account menu

sofalcone

Known as: 2-carboxymethoxy-4,4'-bis(3-methyl-2-butenyloxy)chalcone 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Objective To study in vivo pharmacokinetic characteristics of sofalcone in rats.Methods HPLC method was established to determine… 
2005
2005
AIM: The mucoprotective agents, sofalcone and polaprezinc have anti-Helicobacter pylori ( H pylori)activities. We determined the… 
1997
1997
Une cinetique de premier ordre et le modele de dissolution de Wagner ont ete mis en oeuvre afin d'obtenir un indice correct de… 
1987
1987
Enzymatic sulfation of mucous glycoprotein (GP) was studied in gastric mucosa of rat. After rat stomach was incubated with [35S… 
1986
1986
The effects of sodium taurocholate (TCA) and sofalcone on prostaglandin (PG) metabolism in rat gastric mucosa were examined. TCA… 
1986
1986
Sofalcone prevented the formation of lesions by 50% ethanol and aspirin dose dependently, prevented the decrease in the gastric… 
1985
1985
The effect of 2'-carboxymethoxy-4,4'-bis(3-methyl-2-butenyloxy)-chalcone (sofalcone, Solon) on 0.6N HCl-induced gastric lesions… 
1985
1985
Five dihydrochalcone derivatives, 2'-carboxymethoxy-4, 4'-bis (3-methyl-2-butenyloxy) dihydrochalcone (M-6-b), 2', 4-bis… 
1985
1985
The biosynthesis of rat gastric glycoproteins with or without sulfate was investigated in rats subjected to restraint and water… 
1984
1984
The gastric cytoprotective action of prostaglandin E2 (PGE2) and sofalcone was studied in rats. The in vitro incorporating…